IL6 and COVID-19: Moreover, the COVID-19-induced inflammation and cytokine storm (CS), which are characterized by profound elevations in the levels of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6, lead to peripheral insulin resistance (IR) (13).